Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valens Company Inc (The) Ordinary Shares VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada and other countries, and it generates a majority of revenue from the Cannabis operations segment.


OTCQX:VLNCF - Post by User

Valens Company Inc (The) Ordinary Shares
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(23)
•••
Post by chermanon Apr 20, 2022 9:17pm
197 Views
Post# 34618762

RE:RE:Multiple insiders buying

RE:RE:Multiple insiders buying
I can't agree with you. I believe this stock is at a turning point now. Don't forget the financing was recently done at $2.65 a share and I have no doubt they did their own DD before investing tens of millions in this Company. Analysts have around $10 price target on the stock. Book value is around $3. Personally, I'm buying all that I can at these levels.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities